These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17367578)

  • 1. Neural correlates of 'functional' symptoms in neurology.
    Montoya A; Price BH; Lepage M
    Funct Neurol; 2006; 21(4):193-7. PubMed ID: 17367578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysterical conversion and brain function.
    Vuilleumier P
    Prog Brain Res; 2005; 150():309-29. PubMed ID: 16186033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging studies of functional neurologic disorders.
    Aybek S; Vuilleumier P
    Handb Clin Neurol; 2016; 139():73-84. PubMed ID: 27719879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional neuroimaging correlates of psychogenic versus organic dystonia.
    Schrag AE; Mehta AR; Bhatia KP; Brown RJ; Frackowiak RS; Trimble MR; Ward NS; Rowe JB
    Brain; 2013 Mar; 136(Pt 3):770-81. PubMed ID: 23436503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain circuits implicated in psychogenic paralysis in conversion disorders and hypnosis.
    Vuilleumier P
    Neurophysiol Clin; 2014 Oct; 44(4):323-37. PubMed ID: 25306073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on functional neuroimaging of parkinsonism and dystonia.
    van Eimeren T; Siebner HR
    Curr Opin Neurol; 2006 Aug; 19(4):412-9. PubMed ID: 16914982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging psychogenic movement disorders.
    Mehta AR; Rowe JB; Schrag AE
    Curr Neurol Neurosci Rep; 2013 Nov; 13(11):402. PubMed ID: 24057974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve ultrasound and magnetic resonance imaging in the diagnosis of neuropathy.
    Goedee HS; van der Pol WL; Hendrikse J; van den Berg LH
    Curr Opin Neurol; 2018 Oct; 31(5):526-533. PubMed ID: 30153189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the placebo effect: contributions from neuroimaging.
    Lidstone SC; Stoessl AJ
    Mol Imaging Biol; 2007; 9(4):176-85. PubMed ID: 17334853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional neurological symptoms.
    Stone J
    J R Coll Physicians Edinb; 2011 Mar; 41(1):38-41; quiz 42. PubMed ID: 21365066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Software to Hardware: A Case Series of Functional Neurological Symptoms and Cerebrovascular Disease.
    Coebergh J; Habib S; Teodoro T; Edwards M; Butler M
    J Neuropsychiatry Clin Neurosci; 2024; 36(3):206-213. PubMed ID: 38343312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis.
    Dickstein SG; Bannon K; Castellanos FX; Milham MP
    J Child Psychol Psychiatry; 2006 Oct; 47(10):1051-62. PubMed ID: 17073984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.
    Playford ED; Jenkins IH; Passingham RE; Nutt J; Frackowiak RS; Brooks DJ
    Ann Neurol; 1992 Aug; 32(2):151-61. PubMed ID: 1510355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis.
    Hideyama T; Momose T; Shimizu J; Tsuji S; Kwak S
    Arch Neurol; 2006 Dec; 63(12):1719-22. PubMed ID: 17172610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of neurological symptoms of psychogenic origin].
    Mumenthaler M
    Schweiz Rundsch Med Prax; 1992 Nov; 81(48):1446-51. PubMed ID: 1448639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paralimbic and medial prefrontal cortical involvement in neuroendocrine responses to traumatic stimuli.
    Liberzon I; King AP; Britton JC; Phan KL; Abelson JL; Taylor SF
    Am J Psychiatry; 2007 Aug; 164(8):1250-8. PubMed ID: 17671289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Does Neuroscience Tell Us About the Conversion Model of Functional Neurological Disorders?
    Cretton A; Brown RJ; LaFrance WC; Aybek S
    J Neuropsychiatry Clin Neurosci; 2020; 32(1):24-32. PubMed ID: 31619119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subdural motor cortex stimulation in Parkinson's disease does not modify movement-related rCBF pattern.
    Strafella AP; Lozano AM; Lang AE; Ko JH; Poon YY; Moro E
    Mov Disord; 2007 Oct; 22(14):2113-6. PubMed ID: 17894326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiological characterization of the 'new anatomy' and motor control that results from neurological injury or disease.
    McKay WB
    Clin Neurol Neurosurg; 2012 Jun; 114(5):447-54. PubMed ID: 22310999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.